• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

BMO Equal Weight US Health Care Hedged to CAD Index ETF

+ Add to Watchlist

ZUH:CN

40.1300 CAD 0.2700 0.68%

As of 15:59:29 ET on 12/19/2014.

Snapshot for BMO Equal Weight US Health Care Hedged to CAD Index ETF (ZUH)

Open: 40.0000 High - Low: 40.3100 - 39.8600 Primary Exchange: Toronto
Volume: 57,378 52-Week Range: 28.7400 - 40.3100 Beta vs DJLHECHT: 0.9783

ETF Chart for ZUH

No chart data available.
  • ZUH:CN 40.1200
  • 1D
  • 1M
  • 1Y
39.8600
Interactive ZUH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ZUH

BMO Equal Weight US Health Care Hedged to CAD Index ETF is an exchange-traded fund incorporated in Canada. The ETF has been designed to replicate, to the extent possible, the Dow Jones U.S. Large-Cap Health Care Equal Weight Total Stock Market Index Canadian Dollar Hedged. The Fund seek to invest in and hold the Constituent Securities of the Index.

Inception Date: 2010-05-25 Telephone: 1-416-359-5000
Managers: -
Web Site: www.bmoetfs.com

Fundamentals for ZUH

NAV (on 2014-12-19) 40.0902
Assets (M) (on 2014-10-31) 143.6601
Shares out (M) 4.60
Market Cap (M) 184.60
% Premium 0.10
Average 52-Week % Premium 0.0151
Fund Leveraged N

Dividends for ZUH

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-12-24) 0.1100
Dividend Yield (ttm) 0.29%

Performance for ZUH

1-Month +2.97% 1-Year +38.71%
3-Month +11.09% 3-Year +34.25%
Year To Date +35.49% 5-Year -
Expense Ratio 0.40

Top Fund Holdings for ZUH

Filing Date: 12/18/2014
Name Position Value % of Total
Edwards Lifesciences Corp 29,891 4,555,318 2.476%
CareFusion Corp 64,240 4,417,432 2.401%
Celgene Corp 32,582 4,401,615 2.393%
Vertex Pharmaceuticals Inc 32,058 4,377,674 2.380%
Allergan Inc/United States 17,614 4,334,563 2.356%
Becton Dickinson and Co 26,217 4,269,980 2.321%
Amgen Inc 21,625 4,225,590 2.297%
Regeneron Pharmaceuticals Inc 8,597 4,225,524 2.297%
Bristol-Myers Squibb Co 59,297 4,180,688 2.273%
Mylan Inc/PA 63,325 4,173,840 2.269%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil